Regeneron suspends COVID-19 antibody trial among sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its COVID-19 an...
A Common Steroid May Reduce the Risk of Death in the Sickest COVID-19 Patients
COVID-19 has been ravaging the world for more than...